Featured

VBI-1901: Interim Phase 2a Data & Clinical Update

By November 19, 2020No Comments

Jeff Baxter and David E. Anderson, Ph.D., discuss updated Phase 2a (Part B) data of VBI-1901 in recurrent GBM patients, as presented at SNO 2020.